Tuesday, June 16, 2026

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Anthropic vs. OpenAI: Who Will Dominate the Corporate AI Market in 2026?

Anthropic partners with private equity firms to boost AI adoption and secure semiconductor infrastructure amid rising competition.

Apple’s AI Claims Spark Legal Trouble – Seoul YMCA Demands Investigation

Seoul YMCA urges investigation of Apple for misleading iPhone 16 AI claims, citing false advertising and consumer deception.

CARS

TECH

FUTURE

HEALTH